ÇѸ²´ëÇб³¼º½Éº´¿ø

±è¼ºÀº ±³¼ö

  • Àü¹®¼¾ÅÍ °£¼ÒÈ­±â¼¾ÅÍ ¾Ï¼¾ÅÍ
  • Áø·á°ú ¼ÒÈ­±â³»°ú

Àü¹®Áø·áºÐ¾ß

Áö¹æ°£,°£¿°,°£°æº¯,°£¾Ï

ÀüÈ­ ¿¹¾à 1577-1801
±³¼ö´Ô»çÁø

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2026-06-29 ~ 2026-07-04)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ¼¾ÅÍÁø·á¼¾ÅÍÁø·á
¿ÀÈÄ ¼¾ÅÍÁø·á
±³¼ö´Ô »çÁø

±âº»Á¤º¸

ÇзÂ

ÇзÂ

2008.03 ~ 2010.02¿ï»ê´ëÇб³ ´ëÇпø ¹Ú»ç

2005.03 ~ 2007.02ÇѸ²´ëÇб³ ´ëÇпø ¼®»ç

1996.03 ~ 2002.02ÇѸ²´ëÇб³ Àǰú´ëÇÐ Çлç

°æ·Â

°æ·Â

ÇѸ²´ëÇб³¼º½Éº´¿ø ¼ÒÈ­±â³»°ú ±³¼ö

ÇѸ²´ëÇб³ Àǰú´ëÇÐ ³»°ú ºÎ±³¼ö

UCSD (University of California San Diego) Visiting Scholar

ÇѸ²´ëÇб³ Àǰú´ëÇÐ ³»°ú Á¶±³¼ö

ÇѸ²´ëÇб³ Àǰú´ëÇÐ ³»°ú ºÎ±³¼ö

ÇѸ²´ëÇб³ Àǰú³»ÇÐ ÀÇÇб³À°ÇÐ °âÀÓ±³¼ö

¼­¿ïÀÇ·á¿ø ¼ÒÈ­±â³»°ú ÃËŹÀü¹®ÀÇ

¼­¿ï¾Æ»êº´¿ø ¼ÒÈ­±â³»°ú ÀüÀÓÀÇ

ÇÐȸȰµ¿

ÇÐȸȰµ¿

´ëÇÑÀÓ»óÃÊÀ½ÆÄÇÐȸ È«º¸ÀÌ»ç

´ëÇѰ£ÇÐȸ ¾ËÄڿÿ¬±¸È¸ Ãѹ«ÀÌ»ç

´ëÇѰ£ÇÐȸ Áö¹æ°£¿¬±¸È¸ ´ë¿ÜÇù·ÂÀÌ»ç

´ëÇѰ£ÇÐȸ ÇмúÀ§¿øÈ¸ À§¿ø

´ëÇѰ£ÇÐȸ ÀÇ·áÁ¤Ã¥À§¿øÈ¸ À§¿ø

´ëÇѰ£ÇÐȸ È«º¸ÀÌ»ç (Àü)

´ëÇѰ£¾ÏÇÐȸ ±³À°ÀÌ»ç (Àü)

Çѱ¹È£½ºÇǽº¿ÏÈ­ÀÇ·áÇÐȸ ¹«ÀÓ¼ÒÀÌ»ç (Àü)

´ëÇѰ£¾ÏÇÐȸ º¸ÇèÀ§¿øÈ¸ À§¿ø (Àü)

´ëÇÑÀÓ»óÃÊÀ½ÆÄÇÐȸ ÇмúÀ§¿ø (Àü)

´ëÇÑÀÓ»óÃÊÀ½ÆÄÇÐȸ ´ë¿ÜÇù·ÂÀ§¿ø (Àü)

´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ Á¤È¸¿ø

´ëÇѳ»°úÇÐȸ Á¤È¸¿ø

´ëÇѼÒÈ­±âÇÐȸ Á¤È¸¿ø

´ëÇѰ£¾ÏÇÐȸ Á¤È¸¿ø

À¯·´°£ÇÐȸ Á¤È¸¿ø

Çѱ¹ÀÇ·á½Ã¹Ä·¹À̼ÇÇÐȸ Á¤È¸¿ø

´ëÇѰ£ÇÐȸ 2019 °£°æº¯Áõ °¡À̵å¶óÀÎ ÆíÁýÀ§¿ø

´ëÇѰ£ÇÐȸ Á¤È¸¿ø

¾Æ½Ã¾ÆÅÂÆò¾ç°£ÇÐȸ Á¤È¸¿ø

¼ö»óÀÌ·Â

¼ö»óÀÌ·Â

2017º¸°Çº¹ÁöºÎ Àå°ü ǥâ

2012À¯·´°£ÇÐȸ (EASL) Young investigator award Top 10%

2008¾Æ½Ã¾ÆÅÂÆò¾ç°£ÇÐȸ (APASL) Young investigator award

³í¹®

Standard-Dose Ursodeoxycholic Acid Improves Biochemical Liver Function and Fibrosis in Chronic Liver Disease: Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (Journal of Korean Medical Science)

Aetiology of chronic liver disease is a valuable factor for stratifying adverse outcomes of acute decompensation: prospective observational study (ANNALS OF MEDICINE)

Clinical significance of citrullinated glial fibrillary acidic protein inpredicting outcomes in hepatocellular carcinoma (World Journal of Gastrointestinal Oncology)

Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs (JOURNAL OF VIRAL HEPATITIS)

Impact of metabolic dysfunction on treatment responses to nucleos(t)ide analogues in chronic hepatitis B: a retrospective multi-center REAL-B cohort study (ECLINICALMEDICINE)

Longitudinal Effects of Glecaprevir/Pibrentasvir on Liver Function, Fibrosis, and Hepatocellular Carcinoma Risk in Chronic Hepatitis C: A Prospective Multicenter Cohort Study (MEDICINA-LITHUANIA)

Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues (CLINICAL AND MOLECULAR HEPATOLOGY)

Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study (LANCET GASTROENTEROLOGY & HEPATOLOGY)

Real-World Use of Terlipressin in Cirrhosis and Acute Kidney Injury: Frequent Use Beyond Hepatorenal Syndrome (CLINICAL GASTROENTEROLOGY AND HEPATOLOGY)

High cellular prion protein expression in cholangiocarcinoma: A marker for early postoperative recurrence and unfavorable prognosis (WORLD JOURNAL OF GASTROINTESTINAL SURGERY)

°Ç°­¸Å°ÅÁø